UNSPSC 51144106: Amfetaminil or amphetaminil

This classification denotes a cns stimulant with the molecular formula C17H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0XU0V77JVE, chemically known as benzeneacetonitrile, alpha-((1-methyl-2-phenylethyl)amino)- (9ci) but more generally known as amfetaminil, which bears US NIH Compound Identifier 28615. European Medicines Agency schedules Amfetaminil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05419MIG. The term AMFETAMINIL is an International Non-Proprietary Name.

AMFETAMINIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Amfetaminil or amphetaminil bears US NLM identifiers UMLS ID C2698084 and NCI Concept Code C74237. SMILES: CC(CC1=CC=CC=C1)NC(C#N)C2=CC=CC=C2.

UNSPSC 51144106 Amfetaminil or amphetaminil is a Commodity code that does not match the work actually being solicited under it in recent state and local opportunities. The recent opportunities tagged to this code involve procurement of naloxone (an opioid antagonist), generic pharmaceuticals and over-the-counter products through cooperative purchasing, and direct-to-manufacturer prescription program capabilities — none of which align with the code's nominal scope of amphetaminil, a central nervous system stimulant. This mismatch suggests either a systematic tagging error in the source database or that the code is being used as a catch-all for pharmaceutical procurement activity outside its intended domain.

Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon). Recent opportunities span a pre-bid phase RFI from Texas HHS on direct-to-manufacturer prescription programs (posted April 3, 2026), a competitive bid from Seminole County for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2023), and a multistate RFP from MMCAP for generic pharmaceuticals and OTC products through authorized wholesalers (S1070000015802, due March 26, 2026, with a questions cutoff of February 18, 2026). No opportunities reflecting actual amphetaminil procurement appear in the recent activity block. The code shows little relevant recent activity and warrants review for proper taxonomy alignment before building a pursuit strategy.